Exhibit 31.2

                                  CERTIFICATION

I, Huizhen Yu, certify that:


      1.    I have  reviewed  this  report on Form  10-QSB/A  of China  Medicine
            Corporation;


      2.    Based on my  knowledge,  this  report  does not  contain  any untrue
            statement  of a  material  fact  or omit to  state a  material  fact
            necessary to make the statements made, in light of the circumstances
            under which such  statements  were made, not misleading with respect
            to the period covered by this report;

      3.    Based on my knowledge, the financial statements, and other financial
            information included in this report,  fairly present in all material
            respects the financial  condition,  results of  operations  and cash
            flows of the  registrant  as of, and for,  the periods  presented in
            this report;

      4.    The registrant's  other certifying  officer(s) and I are responsible
            for establishing and maintaining  disclosure controls and procedures
            (as defined in  Exchange  Act Rules  13a-15(e)  and  15d-15(e))  and
            internal  control over  financial  reporting (as defined in Exchange
            Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

            a) Designed such disclosure controls and procedures,  or caused such
      disclosure  controls and procedures to be designed under our  supervision,
      to ensure that material information relating to the registrant,  including
      its consolidated subsidiaries,  is made known to us by others within those
      entities,  particularly  during the  period in which this  report is being
      prepared;

            b) [Omitted according to the SEC Release Nos. 33-8618; 34-52492];

            c)  Evaluated  the  effectiveness  of  the  registrant's  disclosure
      controls and procedures and presented in this report our conclusions about
      the effectiveness of the disclosure  controls and procedures as of the end
      of the period covered by this report based on such evaluation; and

            d) Disclosed in this report any change in the registrant's  internal
      control over  financial  reporting that occurred  during the  registrant's
      most recent fiscal quarter that has materially affected,  or is reasonably
      likely to  materially  affect,  the  registrant's  internal  control  over
      financial reporting; and

      5.    The registrant's  other certifying  officer(s) and I have disclosed,
            based  on our  most  recent  evaluation  of  internal  control  over
            financial  reporting,  to the  registrant's  auditors  and the audit
            committee of registrant's  board of directors (or persons performing
            the equivalent function):

            a) all  significant  deficiencies  and  material  weaknesses  in the
      design or operation of internal  controls over financial  reporting  which
      are  reasonably  likely to adversely  affect the  registrant's  ability to
      record, process, summarize and report financial information; and

            b) Any fraud,  whether or not material,  that involves management or
      other employees who have a significant role in the  registrant's  internal
      control over financial reporting.


Date:    September 20, 2006


/s/ Huizhen Yu
--------------------------------
Huizhen Yu
Chief Financial Officer